The Netherlands Chlamydia Cohort Study: assessing the risk of late complications after Chlamydia trachomatis infection in women

The Netherlands Chlamydia Cohort Study: assessing the risk of late complications after Chlamydia trachomatis infection in women - The NEtherlands Chlamydia Cohort STudy (NECCST)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55823

Enrollment

14685

Registered

2015-10-13

Start date

2015-11-05

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chlamydia Chlamydia trachomatis

Interventions

None listed

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Being a women; - Participated in at least one round of the Chlamydia Screening Implementation between 2008 and 2011; - Given informed consent in the Chlamydia Screening Implementation to be contacted again for future STI-related research.

Exclusion criteria

Exclusion criteria: - Not living in the Netherlands anymore; - No traceable address information.

Design outcomes

Primary

Measure	Time frame
The main outcomes of the study are PID, ectopic pregnancy, tubal infertility and time to pregnancy. The primary study parameter is the presence of a previous Ct infection.	—

Secondary

Measure	Time frame
The secondary study parameters include candidate host genetic biomarkers (SNPs) and behavioural, demographic, and pathogen factors possibly associated with the development of Ct related complications.	—

Countries

Netherlands

Outcome results